see here

first_text= Satellite Symposium: Innovative approach in the treatment of osteoporosis 27.06.2013, Pravets PROLIA – first approved human monoclonal antibody for the treatment of postmenopausal osteoporosis 9.10.2010, Golden Sands PROLIA – prevention of Fractures in postmenopausal women with osteoporosis 2.07.2010, Nesebar Targeting RANK Ligand to inhibit Osteoplast-Driven Bone Loss 2.07.2010, Nesebar PROLIA – the first and only approved RANK Ligand Inhibitor for the treatment of osteoporosis in postmenopausal women at increased risk of fractures 2.07.2010, Nesebar